JP is a 60 year old South African male who experienced a heart attack at 51 years of age. After diagnosis of Coronary Artery Disease was made a stent placement was performed. Dietary and lifestyle changes were implemented immediately by JP following the hospitalization. Unfortunately, 3 years later, JP suffered four additional heart attacks.

During the hospitalization, the angiogram revealed the right and left coronary arteries were obstructed 100% and 40%, respectively, thus determining that JP was not a good candidate for bypass surgery. At the time of the last hospitalization, JP had decreased energy and experienced “stable” angina with any exertion, and his overall quality of life was greatly compromised. JP was put on a medication regimen which consisted of Atenolol 50mg daily, The Therapeutic Potential of Stimulating Endogenous Stem Cell Mobilization 185 Perindopril 4 mg daily, Elantan 20 mg twice per day, Simvostatin 20 mg daily, Adelat xl 30mg daily, and Aspirin 1 per day.

JP was then put on a list for possible heart transplant.

Three weeks after discharge JP began consuming SE (Stem Enhance), 1 gram three times per day.

After 3 months of taking the product, he received a call for a possible heart transplant and returned to see his cardiologist for evaluation and comprehensive testing. The cardiologist reported that JP was making a remarkable recovery, the heart transplant surgery was postponed.

Four months later JP was re-evaluated and found to have made a complete recovery. JP has since been returning at 6 month intervals for follow up evaluation, and to date he has been stable with no further coronary incidents. The evaluations and most recent ECG conclude that JP has normal heart function.

Presently, JP shares that he is not on any medications, blood pressure is 126/65 mm Hg, he continues to take SE and experiences good quality of life.

Christian Drapeau, a member of Gitte Jensen, Ph.D, research team that created the patented Stem Enhance ULTRA